SCHEMBL20969680

SCHEMBL20969680

COc1ccc(CCN(c2nc3cc(Br)ccc3s2)C(C)c2ccc(C(=O)O)cc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KARS1 Q15046 1/20 0.46
HDAC6 Q9UBN7 1/20 0.41
FFAR1 O14842 1/20 0.40
MAPT P10636 1/20 0.40
TAS2R14 Q9NYV8 2/20 0.39
LPAR1 Q92633 2/20 0.39
LPAR5 Q9H1C0 2/20 0.39
PPARA Q07869 4/20 0.38
TUBB4A P04350 1/20 0.38
TUBB P07437 1/20 0.38
TUBA3C P0DPH7 1/20 0.38
TUBA1B P68363 1/20 0.38
TUBA4A P68366 1/20 0.38
TUBB4B P68371 1/20 0.38
TUBB3 Q13509 1/20 0.38
TUBB2A Q13885 1/20 0.38
TUBB8 Q3ZCM7 1/20 0.38
TUBA3E Q6PEY2 1/20 0.38
TUBA1A Q71U36 1/20 0.38
TUBA1C Q9BQE3 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20969731 0.93 KARS1 (0.46) KARS1FFAR1MAPTTAS2R14LPAR1
SCHEMBL20969683 0.90 KARS1 (0.47) KARS1HDAC6FFAR1MAPTTAS2R14
SCHEMBL20969716 0.90 KARS1 (0.46) KARS1HDAC6FFAR1MAPTTAS2R14
SCHEMBL20969737 0.90 KARS1 (0.46) KARS1HDAC6FFAR1MAPTTAS2R14
SCHEMBL20969604 0.87 KARS1 (0.44) KARS1HDAC6FFAR1MAPTTAS2R14
SCHEMBL20969622 0.87 KARS1 (0.47) KARS1FFAR1MAPTTAS2R14LPAR1
SCHEMBL20969664 0.85 PPARD (0.47) KARS1FFAR1MAPTTAS2R14LPAR1
SCHEMBL20969586 0.84 PPARD (0.46) KARS1FFAR1MAPTTAS2R14LPAR1
SCHEMBL20969558 0.84 KARS1 (0.65) KARS1HDAC6MAPTTAS2R14LPAR1
SCHEMBL20969667 0.82 CSNK1D (0.49) KARS1FFAR1MAPTPPARALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP claimed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US claimed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US claimed
EP-3483149-B1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME YUHAN CORP (KR) 2021-01-13 EP disclosed
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same YUHAN CORPORATION (KR) 2019-08-20 US disclosed
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same YUHAN CORPORATION (KR) 2019-05-16 US disclosed
EP-3483149-A1 BENZO[D]THIAZOLE DERIVATIVE OR SALT THEREOF, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME Yuhan Corporation (KR) 2019-05-15 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190142809-A1 Benzo[D]Thiazole Derivative Or Salt Thereof, And Pharmaceutical Composition Including Same ILK, SBDS, BDKRB1 KARS1 6/4885HDAC6 389/4885FFAR1 2815/4885
US-10383859-B2 Benzo[d]thiazole derivative or salt thereof, and pharmaceutical composition including same ILK, SBDS, BDKRB1 KARS1 6/4885HDAC6 389/4885FFAR1 2815/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.